Columbus, United States
MavenView, founded in 2015 and headquartered in the United States, is at the forefront of transforming research into impactful solutions. Upholding its slogan, "At MavenVue, we drive research to commercialization and benefits to end-users," the company operates within the Analytics, Biopharma, Biotechnology, Information Technology, and Life Sciences industries.
MavenView offers strategic insights for health and life science professionals, enabling thorough exploration of connections and patterns critical for innovation. Its offerings include high-level overviews and in-depth analysis of technologies, biological therapies, and rare diseases. This supports competitive intelligence, licensing, and M&A activities, catering to evolving industry needs.
The company last secured a $737.74K Seed Round investment on 02 October 2018. This funding illustrates investor confidence in MavenView’s potential to leverage strategic intelligence within the biopharma and life sciences space.
